New knee injection shows promise in early safety trial
Disease control
Completed
This early-stage study tested whether an experimental drug called CYT-108 is safe for people with mild to moderate knee osteoarthritis. Nineteen participants received either the drug or a placebo injection into the knee, and were monitored for 26 weeks. The main goal was to check…
Phase: PHASE1 • Sponsor: Cytonics Corporation • Aim: Disease control
Last updated May 22, 2026 13:50 UTC